Ocial, Analie T.
HRN: 25-58-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/27/2024
08/03/2024
IV
500mg
Every 8 Hours
UTI, Cannot Rule Out Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes